Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia

被引:226
作者
Sebastiani, P
Ramoni, MF [1 ]
Nolan, V
Baldwin, CT
Steinberg, MH
机构
[1] Harvard Univ, Sch Med, Childrens Hosp Informat Program, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA
[3] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA
[5] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA
[6] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
关键词
D O I
10.1038/ng1533
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Sickle cell anemia (SCA) is a paradigmatic single gene disorder caused by homozygosity with respect to a unique mutation at the beta-globin locus. SCA is phenotypically complex, with different clinical courses ranging from early childhood mortality to a virtually unrecognized condition. Overt stroke is a severe complication affecting 6 - 8% of individuals with SCA. Modifier genes might interact to determine the susceptibility to stroke, but such genes have not yet been identified. Using Bayesian networks, we analyzed 108 SNPs in 39 candidate genes in 1,398 individuals with SCA. We found that 31 SNPs in 12 genes interact with fetal hemoglobin to modulate the risk of stroke. This network of interactions includes three genes in the TGF-beta pathway and SELP, which is associated with stroke in the general population. We validated this model in a different population by predicting the occurrence of stroke in 114 individuals with 98.2% accuracy.
引用
收藏
页码:435 / 440
页数:6
相关论文
共 30 条
[1]   Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study [J].
Adams, RJ ;
Brambilla, DJ ;
Granger, S ;
Gallagher, D ;
Vichinsky, E ;
Abboud, MR ;
Pegelow, CH ;
Woods, G ;
Rohde, EM ;
Nichols, FT ;
Jones, A ;
Luden, JP ;
Bowman, L ;
Hagner, S ;
Morales, KH ;
Roach, ES .
BLOOD, 2004, 103 (10) :3689-3694
[2]   Prevention of a first stroke by transfusions in children with sickle, cell anemia and abnormal results on transcranial Doppler ultrasonography [J].
Adams, RJ ;
McKie, VC ;
Hsu, L ;
Files, B ;
Vichinsky, E ;
Pegelow, C ;
Abboud, M ;
Gallagher, D ;
Kutlar, A ;
Nichols, FT ;
Bonds, DR ;
Brambilla, D ;
Woods, G ;
Olivieri, N ;
Driscoll, C ;
Miller, S ;
Wang, W ;
Hurlett, A ;
Scher, C ;
Berman, B ;
Carl, E ;
Jones, AM ;
Roach, ES ;
Wright, E ;
Zimmerman, RA ;
Waclawiw, M ;
Pearson, H ;
Powars, D ;
Younkin, D ;
El-Gammal, T ;
Seibert, J ;
Moye, L ;
Espeland, M ;
Murray, R ;
McKinley, R ;
McKinley, S ;
Hagner, S ;
Weiner, S ;
Estow, S ;
Yelle, M ;
Brock, K ;
Carter, E ;
Chiarucci, K ;
Debarr, M ;
Feron, P ;
Harris, S ;
Hoey, L ;
Jacques, K ;
Kuisel, L ;
Lewis, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :5-11
[3]   ALPHA-THALASSEMIA AND STROKE RISK IN SICKLE-CELL-ANEMIA [J].
ADAMS, RJ ;
KUTLAR, A ;
MCKIE, V ;
CARL, E ;
NICHOLS, FT ;
LIU, JC ;
MCKIE, K ;
CLARY, A .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 45 (04) :279-282
[4]   Are there clinical phenotypes of homozygous sickle cell disease? [J].
Alexander, N ;
Higgs, D ;
Dover, G ;
Serjeant, GR .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (04) :606-611
[5]  
Angerio Allan D, 2003, Crit Care Nurs Q, V26, P225
[6]  
[Anonymous], 1999, Probabilistic Networks and Expert Systems
[7]   The Bayesian revolution in genetics [J].
Beaumont, MA ;
Rannala, B .
NATURE REVIEWS GENETICS, 2004, 5 (04) :251-261
[8]   Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease [J].
Botstein, D ;
Risch, N .
NATURE GENETICS, 2003, 33 (Suppl 3) :228-237
[9]   Requirement of type III TGF-β receptor for endocardial cell transformation in the heart [J].
Brown, CB ;
Boyer, AS ;
Runyan, RB ;
Barnett, JV .
SCIENCE, 1999, 283 (5410) :2080-2082
[10]   Mapping complex disease loci in whole-genome association studies [J].
Carlson, CS ;
Eberle, MA ;
Kruglyak, L ;
Nickerson, DA .
NATURE, 2004, 429 (6990) :446-452